Vascular endothelial growth factor (
VEGF)-D is a secreted
glycoprotein that induces angiogenesis and lymphangiogenesis. It consists of a central domain, containing binding sites for
VEGF receptor-2 (VEGFR-2) and
VEGFR-3, and N- and C-terminal propeptides. It is secreted from the cell as homodimers of the full-length form that can be proteolytically processed to remove the propeptides. It was recently shown, using adenoviral gene delivery, that fully processed
VEGF-D induces angiogenesis in vivo, whereas full-length
VEGF-D does not. To better understand these observations, we monitored the effect of
VEGF-D processing on receptor binding using a full-length
VEGF-D mutant that cannot be processed. This mutant binds
VEGFR-2, the receptor signaling for angiogenesis, with approximately 17,000-fold lower affinity than mature
VEGF-D, indicating the importance of processing for interaction with this receptor. Further, we show that members of the
proprotein convertase (PC) family of
proteases promote
VEGF-D processing, which facilitates the
VEGF-D/VEGFR-2 interaction. The PCs
furin and
PC5 promote cleavage of both propeptides, whereas PC7 promotes cleavage of the C-terminal propeptide only. The finding that PCs promote activation of
VEGF-D and other
proteins with roles in
cancer such as
matrix metalloproteinases, emphasizes the importance of these
enzymes as potential regulators of
tumor progression and
metastasis.